Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 214

Sort by

Sort Order Select

Journal Articles

Potentially Modifiable Risk Factors for 30‐Day Readmission in Adults with Sickle Cell Disease: A National Database Study

Manojna Konda, MD, Arya Mariam Roy, MD, Anusha Jillella, MD, Akshay Goel, MD, Appalanaidu Sasapu, MD

Blood (2019) 134 (Supplement_1): 4857.

https://doi.org/10.1182/blood-2019-132215

Published: 2019

Journal Articles

Thrombotic Thrombocytopenic Purpura and Atypical Hemolytic Uremic Syndrome in Pregnancy: A Single Center Retrospective Review

Pallavi Kopparthy, MD, Anita Rajasekhar, MD

Blood (2019) 134 (Supplement_1): 4899.

https://doi.org/10.1182/blood-2019-131846

Published: 2019

Journal Articles

Implementation of an Evidence-Based Care Pathway for Emergency Department Management of Sickle Cell Vaso-Occlusive Crisis Leads to Improved Clinical Outcomes

Jennifer Yui, MD, Scott A. Peslak, MD PhD, David Lambert, MD, Eric Russell, MD, Farzana Sayani, MD

Blood (2019) 134 (Supplement_1): 4678.

https://doi.org/10.1182/blood-2019-123868

Published: 2019

Journal Articles

Increased Mortality and Bleeding in a Large Cohort of Patients on Heparin Anticoagulation Therapy with Discordant Anti-Factor Xa Activity and Activated Partial Thromboplastin Time (PTT); Implications for Clinical Management

Saurabh Gombar, MD PhD, Derek Boothroyd, PhD, Anandi Krishnan, PhD, Husham Sharifi, MD, Joe Hsu, MD, James Zehnder, MD

Blood (2019) 134 (Supplement_1): 712.

https://doi.org/10.1182/blood-2019-132112

Published: 2019

Journal Articles

Machine Learning Algorithms in Predicting Hospital Readmissions in Sickle Cell Disease

Arisha Patel, MD, Kyra Gan, PhDCandidate, Andrew Li, PhD, Jeremy Weiss, MD PhD, Seyed Mehdi Nouraie, MD PhD, Sridhar Tayur, PhD, Enrico M Novelli, MD MS

Blood (2019) 134 (Supplement_1): 982.

https://doi.org/10.1182/blood-2019-121808

Published: 2019

Journal Articles

Safety of Intravenous Arginine Therapy in Children with Sickle Cell Disease Hospitalized for Vaso-Occlusive Pain: A Randomized Placebo-Controlled Trial in Progress

Claudia R. Morris, MD, Janet Figueroa, MPH, Amanda Watt, Kirshma Khemani, MD, Polly Kumari, MBBS, Morgan Barnett, MPH, Nitya Bakshi, MBBS, MS, Peter A. Lane, MD, Carlton Dampier, MD

Blood (2019) 134 (Supplement_1): 995.

https://doi.org/10.1182/blood-2019-122983

Published: 2019

Journal Articles

Comparison of Outcomes after Early Hospital Discharge (EHD) Following Intensive Induction Vs. Post-Remission Chemotherapy for Adults with Acute Myeloid Leukemia (AML) and Other High-Grade Myeloid Neoplasms

Anna B. Halpern, MD, Nicholas P Howard, Megan Othus, PhD, Paul C. Hendrie, MD PhD, Nikita Vashi Baclig, MD MPH, Sarah A Buckley, MD, Mary-Elizabeth M. Percival, MD, Pamela S. Becker, MD PhD, Bart L. Scott, MD, Vivian G. Oehler, MD, Terry B. Gernsheimer, MD, Sioban B. Keel, MD, Johnnie Orozco, MD, Ryan D. Cassaday, MD, Andrei R Shustov, MD, Garrett Hartley, Verna L Welch, PhD MPH, Elihu H. Estey, MD, Roland B. Walter, MD PhD MS

Blood (2019) 134 (Supplement_1): 1317.

https://doi.org/10.1182/blood-2019-124586

Published: 2019

Journal Articles

Comparative Analysis of Patterns of Infectious Complications of Outpatient Vs. Inpatient Care Following Intensive Induction Chemotherapy for Adults with Acute Myeloid Leukemia (AML) or Other High-Grade Myeloid Neoplasms

Anna B. Halpern, MD, Nicholas P Howard, Megan Othus, PhD, Paul C. Hendrie, MD PhD, Nikita Vashi Baclig, MD MPH, Sarah A Buckley, MD, Mary-Elizabeth M. Percival, MD, Pamela S. Becker, MD PhD, Bart L. Scott, MD, Vivian G. Oehler, MD, Terry B. Gernsheimer, MD, Sioban Keel, MD, Johnnie Orozco, MD, Ryan D. Cassaday, MD, Andrei R Shustov, MD, Garrett Hartley, Verna L Welch, PhD MPH, Elihu H. Estey, MD, Roland B. Walter, MD PhD MS

Blood (2019) 134 (Supplement_1): 1323.

https://doi.org/10.1182/blood-2019-123605

Published: 2019

Journal Articles

Effect of Age on Healthcare Utilization in Patients with Sickle Cell

Nicholas Hamilton, Payal Desai, MD, Nita Williams, Mikaela D. Moore, BS, Andrew I. Schamess, MD

Blood (2019) 134 (Supplement_1): 1019.

https://doi.org/10.1182/blood-2019-127543

Published: 2019

Journal Articles

Morbidity, Mortality, and Healthcare Utilization in a National Cohort of Pediatric Patients with Hemophagocytic Lymphohistiocytosis Who Received Hematopoietic Stem Cell Transplant

Archana Ramgopal, DO, Meghan McCormick, MD, Ram Kalpatthi, MD, Louis Rapkin, MD, James Zullo, Steven William Allen, MD BS

Blood (2019) 134 (Supplement_1): 2183.

https://doi.org/10.1182/blood-2019-132084

Published: 2019

Journal Articles

Differences in Admission Rates Among Patients Treated with Apixaban Vs. Warfarin for Venous Thromboembolism in the Emergency Department

Steven Deitelzweig, MD, Patrick Hlavacek, MPH, Jack Mardekian, PhD, Lisa Rosenblatt, MD MPH, Cristina Russ, MD PhD, Kenneth Tuell, RPh, Melissa Lingohr-Smith, PhD, Jay Lin, PhD MBA, Jennifer D Guo, PhD

Blood (2019) 134 (Supplement_1): 2157.

https://doi.org/10.1182/blood-2019-125845

Published: 2019

Journal Articles

A Clinical Pathway Reduces Admissions for Vaso-Occlusive Pain in Sickle Cell Disease

Wallace Jones, MD, Leann Myers, Aditi Dasgupta, Jessica Debord

Blood (2019) 134 (Supplement_1): 3383.

https://doi.org/10.1182/blood-2019-127097

Published: 2019

Journal Articles

Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell Disease

Jin Han, PharmD, PhD, Santosh L. Saraf, MD, Michel Gowhari, DO, Faiz Ahmed Hussain, MD, Shivi Jain, MD, Laura Kavoliunaite, APN, Robert E. Molokie, MD, Victor R Gordeuk, MD

Blood (2019) 134 (Supplement_1): 3390.

https://doi.org/10.1182/blood-2019-122249

Published: 2019

Journal Articles

Unrelated Cord Blood Transplantation and Post-Transplant Cyclophosphamide (PT-CY)

Patrizia Chiusolo, Andrea Bacigalupo, MD, Simona Sica, MD, Sabrina Giammarco, MD PhD, Elisabetta Metafuni, Federica Sora, MD, Luca Laurenti, MD, Francesco Autore, MD, Idanna Innocenti, MD PhD, Silvia Bellesi, Gina Zini, MD PhD, Maria Bianchi, Caterina Giovanna Valentini, Luciana Teofili, MD

Blood (2019) 134 (Supplement_1): 3332.

https://doi.org/10.1182/blood-2019-130849

Published: 2019

Journal Articles

Lymphoma-Associated Pulmonary Embolism Burden in Hospital Admissions in the United States

Khalid Shalaby, MBBCh, Adriana Kahn, MD, Elizabeth Silver, Kathir Balakumaran, MD, Agnes S. Kim, MD PhD

Blood (2019) 134 (Supplement_1): 3400.

https://doi.org/10.1182/blood-2019-122382

Published: 2019

Journal Articles

Case Management Featuring Community Health Workers Reduces Inpatient Health Care Utilization in Adults with Sickle Cell Disease

Wally R Smith, MD, Daniel Sop, BS,MS, Shirley Johnson, BA, LSW, Thokozeni Lipato, MD, Mica Ferlis, ANP, Caitlin Mcmanus, ANP, Margaret Guy, MD, Sarah Hartigan, MD, Emily Holt, BS, Chantal McHenry, BS, John D. Roberts, MD

Blood (2019) 134 (Supplement_1): 2104.

https://doi.org/10.1182/blood-2019-130441

Published: 2019

Journal Articles

Disease Progression, Hospital Readmissions, and Clinical Outcomes of Patients with Steroid-Refractory Acute Graft-Versus-Host Disease: A Multicenter Chart Review

Jingbo Yu, PhD, Becky Hanna, Dilan Paranagama, PhD, Jackson Tang, Ahmad Naim, MD, John P Galvin, MDMS,MPH

Blood (2019) 134 (Supplement_1): 1994.

https://doi.org/10.1182/blood-2019-127492

Published: 2019

Journal Articles

Emergency Department Encounters, Hospitalizations and ED Reliance Among Medicaid Eligible Patients with Sickle Cell Disease in North Carolina

Paula Tanabe, PhDRN, Nancy Crego, PhD RN, CCRN, CHSE, Christian Douglas, DrPH, Emily Bonnabeau, BA, Marian Earls, MD, Kern Eason, MBA, Elizabeth Merwin, PhD RN, FAAN, Nirmish Shah

Blood (2019) 134 (Supplement_1): 2113.

https://doi.org/10.1182/blood-2019-127196

Published: 2019

Journal Articles

Urban-Rural Variation in Use of Thrombolytic Therapy for Pulmonary Embolism

Jeremy Y Feng, MD, Charles B Ross, MD FACS, FSVS, Rachel P Rosovsky, MDMPH

Blood (2019) 134 (Supplement_1): 3409.

https://doi.org/10.1182/blood-2019-125493

Published: 2019

Journal Articles

Tiered Oral Therapy Protocol for Sickle Cell Vaso-Occlusive Crisis

Margaret Guy, MD, Lauren Magee, PharmD, BCPS, Jessica Keiser, MD, Nicole Carter, RN, MSN, NP-C, DaleMarie Vaughan, PharmD, BCPS, Chantal McHenry, BS, Daniel Sop, BS,MS, Sarah Hartigan, MD, Wally R Smith, MD

Blood (2019) 134 (Supplement_1): 3446.

https://doi.org/10.1182/blood-2019-131298

Published: 2019

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Potentially Modifiable Risk Factors for 30‐Day Readmission in Adults with Sickle Cell Disease: A National Database Study

Thrombotic Thrombocytopenic Purpura and Atypical Hemolytic Uremic Syndrome in Pregnancy: A Single Center Retrospective Review

Implementation of an Evidence-Based Care Pathway for Emergency Department Management of Sickle Cell Vaso-Occlusive Crisis Leads to Improved Clinical Outcomes

Increased Mortality and Bleeding in a Large Cohort of Patients on Heparin Anticoagulation Therapy with Discordant Anti-Factor Xa Activity and Activated Partial Thromboplastin Time (PTT); Implications for Clinical Management

Machine Learning Algorithms in Predicting Hospital Readmissions in Sickle Cell Disease

Safety of Intravenous Arginine Therapy in Children with Sickle Cell Disease Hospitalized for Vaso-Occlusive Pain: A Randomized Placebo-Controlled Trial in Progress

Comparison of Outcomes after Early Hospital Discharge (EHD) Following Intensive Induction Vs. Post-Remission Chemotherapy for Adults with Acute Myeloid Leukemia (AML) and Other High-Grade Myeloid Neoplasms

Comparative Analysis of Patterns of Infectious Complications of Outpatient Vs. Inpatient Care Following Intensive Induction Chemotherapy for Adults with Acute Myeloid Leukemia (AML) or Other High-Grade Myeloid Neoplasms

Effect of Age on Healthcare Utilization in Patients with Sickle Cell

Morbidity, Mortality, and Healthcare Utilization in a National Cohort of Pediatric Patients with Hemophagocytic Lymphohistiocytosis Who Received Hematopoietic Stem Cell Transplant

Differences in Admission Rates Among Patients Treated with Apixaban Vs. Warfarin for Venous Thromboembolism in the Emergency Department

A Clinical Pathway Reduces Admissions for Vaso-Occlusive Pain in Sickle Cell Disease

Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell Disease

Unrelated Cord Blood Transplantation and Post-Transplant Cyclophosphamide (PT-CY)

Lymphoma-Associated Pulmonary Embolism Burden in Hospital Admissions in the United States

Case Management Featuring Community Health Workers Reduces Inpatient Health Care Utilization in Adults with Sickle Cell Disease

Disease Progression, Hospital Readmissions, and Clinical Outcomes of Patients with Steroid-Refractory Acute Graft-Versus-Host Disease: A Multicenter Chart Review

Emergency Department Encounters, Hospitalizations and ED Reliance Among Medicaid Eligible Patients with Sickle Cell Disease in North Carolina

Urban-Rural Variation in Use of Thrombolytic Therapy for Pulmonary Embolism

Tiered Oral Therapy Protocol for Sickle Cell Vaso-Occlusive Crisis

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only